Skip to main content
Home
About
About CPD Network
Mission & Vision
Purpose
Governance
Compliance
Physician Organization Checklist
Microsites
Experts
Members
Contact
Login
Home
About
About CPD Network
Mission & Vision
Purpose
Governance
Compliance
Physician Organization Checklist
Microsites
Experts
Members
Contact
Login
Home
Microsites
Under the Mask
FR
EN
Main Resources for Speakers
Speaker Training Video
How to Navigate the Animations
Program Deck
Virtual
In-person
Speaker Guide
Overview of Patient Cases
Patient Cases
Patient Cases
Ms. O: Obesity
Ms. C: CV Disease
Mr. E: Fatigue and Shortness of Breath
Ms. R: Chronic Kidney Disease
Ms. I: Heart Failure
Mr. F: CV Risk Factors
Mr. A: Aged 80, Independent
Mr. D: Newly Diagnosed with T2D
Additional Resources
Drug Brand Names
Antihyperglycemic Agents and Kidney Function
Roadmap for Identifying HFpEF
RAMQ Reimbursement Criteria
Program References
Program Resources
Program Slides
View online
|
Download
Program References
Download
Drug Brand Names
Antihyperglycemic Agents and Kidney Function
Roadmap for Identifying HFpEF
RAMQ Reimbursement Criteria
Study Publications
A systematic review and meta-analysis of cardiovascular and kidney outcome trials with GLP-1 receptor agonists
A meta-analysis of cardiovascular and kidney outcome trials with SGLT2 inhibitors
A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
EMPEROR-Preserved: Empagliflozin in Heart Failure with a Preserved Ejection Fraction
DELIVER: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
DAPA-CKD: Dapagliflozin in Patients with Chronic Kidney Disease
EMPA-Kidney: Empagliflozin in Patients with Chronic Kidney Disease
CREDENCE: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Guidelines
Diabetes Canada 2020 Clinical Practice Guidelines – Quick Reference Guide
Diabetes Canada – Special Article 2022: Remission of Type 2 Diabetes
Obesity Canada – Obesity in adults: A clinical practice guideline
KDIGO Heat Map to Calculate the Risk of CDK Progression
CCS/CHFS Heart Failure Guidelines 2021 Update
EXIT
cpdisup
